Meckler Jeffrey A
SEC Form 4 insider trading activity
Meckler Jeffrey A has filed 4 SEC Form 4 filings (10 transaction rows) across 2 companies, including TVTX, INDP, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 11, 2026.
On the most recent filing, Meckler Jeffrey A is listed as Director at Travere Therapeutics, Inc. Inside the rolling window, Meckler Jeffrey A reported no open-market purchases and 2 open-market sales totaling $1.7M in TVTX. The largest disclosed transaction in the window is a sale of 20,000 TVTX shares on Sep 10, 2026, worth $1.3M.
Companies traded
Other insiders at TVTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.7M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Meckler Jeffrey A made?
Meckler Jeffrey A has filed 4 SEC Form 4 filings (10 transaction rows) across 2 companies, including TVTX, INDP since 2025.
Which companies does Meckler Jeffrey A trade?
Meckler Jeffrey A has filed SEC Form 4 disclosures for 2 companies, including TVTX, INDP.
When was Meckler Jeffrey A's most recent SEC Form 4 filing?
Meckler Jeffrey A's most recent SEC Form 4 filing on Tracefour is dated Sep 11, 2026.
What is Meckler Jeffrey A's total buy and sell value in the current window?
Inside the rolling retention window, Meckler Jeffrey A bought $0 and sold $1.7M based on SEC Form 4 filings.
What was Meckler Jeffrey A's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 20,000 TVTX shares on 2026-09-10, worth $1.3M, per SEC Form 4 filings.